Response of Degarelix treatment in human prostate cancer monitored by HR-MAS (1)H NMR spectroscopy

INTRODUCTION: The androgen receptor (AR) is the master regulator of prostate cancer cell metabolism. Degarelix is a novel gonadotrophin-releasing hormone blocker, used to decrease serum androgen levels in order to treat advanced human prostate cancer. Little is known of the rapid metabolic response...

Descripción completa

Detalles Bibliográficos
Autores principales: Madhu, Basetti, Shaw, Greg L., Warren, Anne Y., Neal, David E., Griffiths, John R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927592/
https://www.ncbi.nlm.nih.gov/pubmed/27429605
http://dx.doi.org/10.1007/s11306-016-1055-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927592/
https://www.ncbi.nlm.nih.gov/pubmed/27429605
http://dx.doi.org/10.1007/s11306-016-1055-0

Ejemplares similares